Investor Presentaiton

Q1 2023 Financial Highlights Revenue $45.3m 70% YoY reported growth 43% pro forma(1) YoY growth Trailing 12 Month Revenue $164.8m ~52% from Medical Short Distance Pro Forma(1) YoY Growth 12% 148% YoY reported growth MediMobility Organ Transport YoY Revenue Growth 111% Flight Margin 15.8% Adjusted EBITDA ($7.7m) Note: Definition of all non-GAAP numbers and reconciliation to GAAP numbers are provided in the Appendix of this presentation 1. Pro forma growth reflects revenue growth as if Blade had owned the charter and scheduled air mobility businesses of Monacair, Héli Sécurité and Azur Hélicoptère in the prior year period BLADE 22 22

View entire presentation